With all the talk of the various proposed trials, it sounds like the HIV inflammation trial is expected to be a good target.

With the list of potential indications with several being inflammation, why would we not chase a trial in rheumatoid arthritis? It would seem like that would be a slam dunk if our theories are correct and would be easy to meet endpoints and also be a very simple one to conduct.

I know there are a lot of people smarter than me about how this would operate, and we also do not have much cash to drive this. Its just that as soon as people started championing inflammation my first thought was RA would be an easy target and a pretty large market. Perhaps all our board and related scientists are all HIV/Cancer guys?

Some of the side effects of the current RA drugs are not good and LL would be a great if what we theorize is correct. My BIL got it in his late 30's and he had to revamp his entire lifestyle and eating habits to deal with the condition. He has been living with it for more than 15 years.